Cameroon’s HPV Vaccination Crisis – WUENIC 2024 Insights and a Girls-Centered Recovery Plan

Dear Friends,

Your article is truly an eye-opener, and the unfortunate events surrounding the HPV vaccine introduction in Cameroon are deeply concerning. The ongoing debate on whether a single dose or two doses of HPV vaccine should be recommended remains unresolved globally, adding further complexity to program implementation.

The population of Cameroon is roughly equivalent to that of one or two Indian states. Yet, India too has not rolled out the HPV vaccine at a national scale despite having established national guidelines. Some of the possible reasons are as follows:

1. Limited domestic production and pending price negotiation:
   India currently lacks sufficient indigenous vaccine manufacturing capacity for HPV. Price negotiations are also yet to be finalized. For a country of India’s size, self-reliance in vaccine production is crucial to prevent stock-outs and dependency on foreign suppliers.

2. Need for affordable pricing and sustainable financing:
   Given that India’s population is nearly half that of the entire African continent, reasonable pricing and a sustained domestic budget are essential to run such programs without depending on global support. The COVID-19 vaccination drive demonstrated India’s capacity for large-scale, self-financed immunization.

3. Building community confidence:
   India prioritizes addressing community trust, myths, and misconceptions before introducing any new vaccine. The polio eradication experience is a powerful reminder—years of sustained community engagement were required to overcome misinformation and resistance.

4. Strong public health system and monitoring capacity:
   India has a robust public health delivery and monitoring system capable of ensuring effective vaccine rollout. During my tenure as the National Lead at JSI for the pan-India Rotavirus Vaccine introduction (covering 25 million children), I had the opportunity to witness and support the Government of India in overcoming several such implementation challenges.

I sincerely hope Cameroon will also overcome its current bottlenecks and move toward successful and equitable HPV vaccination coverage in the near future.

Warm regards,
Dr. Saumendra Nath Bagchi